C
Courtney Hyland
Researcher at Harvard University
Publications - 6
Citations - 4450
Courtney Hyland is an academic researcher from Harvard University. The author has contributed to research in topics: Copy-number variation & Human genome. The author has an hindex of 2, co-authored 6 publications receiving 4188 citations.
Papers
More filters
Journal ArticleDOI
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Jeffrey A. Engelman,Kreshnik Zejnullahu,Tetsuya Mitsudomi,Youngchul Song,Courtney Hyland,Joon Oh Park,Neal I. Lindeman,Christopher-Michael Gale,Xiaojun Zhao,James J. Christensen,Takayuki Kosaka,Alison J. Holmes,Andrew M. Rogers,Federico Cappuzzo,Tony Mok,Charles Lee,Bruce E. Johnson,Lewis C. Cantley,Pasi A. Jänne +18 more
TL;DR: It is proposed that MET amplification may promote drug resistance in other ERBB-driven cancers as well after it was found that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)–dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors.
Journal ArticleDOI
Copy number variation and evolution in humans and chimpanzees.
George H. Perry,Fengtang Yang,Tomas Marques-Bonet,Carly Murphy,Tomas W Fitzgerald,Arthur Lee,Courtney Hyland,Anne C. Stone,Matthew E. Hurles,Chris Tyler-Smith,Evan E. Eichler,Nigel P. Carter,Charles Lee,Richard Redon +13 more
TL;DR: Functional categories of genes that have likely evolved under purifying or positive selection for copy number changes may have been fixed by positive selection and involved in the adaptive phenotypic differentiation of humans and chimpanzees.
Book ChapterDOI
Copy Number Variation and Human Health
TL;DR: The extent of genetic variation in human populations and its impact on human health is identified and CNVs are genomic gains and losses of 1 kb or larger, differentiating it from other forms of polymorphism and/or repeated DNAs in the human genome.
Posted Content
Office of Technology Transfer - Shanghai Institutes for Biological Sciences (TN)
TL;DR: Zong et al. as discussed by the authors present and future managers at global multinationals who have responsibility for R&D strategy to understand some of the complexities of the Chinese intellectual property environment so that they can build effective participation strategies for their organizations Understanding the misaligned incentives that result in the production of junk patents and the challenges of patent enforcement, as well as the direction of change are vital.
Journal ArticleDOI
D2-07: Mechanisms of activating PI3K signaling in lung cancers that become resistant EGFR tyrosine kinase inhibitors
Jeffrey A. Engelman,Kreshnik Zejnullahu,Tetsuya Mitsudomi,Courtney Hyland,Joon Oh Park,Neal I. Lindeman,Christopher-Michael Gale,Xiaojun Zhao,James D. Christensen,Rogers M. Rogers,Federico Cappuzzo,Tony Mok,Charles Lee,Johnson E. Bruce,Lewis C. Cantley,Pasi A. Jänne +15 more